| 06/01/2026 |
AFINITOR NDA #022334 |
SUPPL-55 |
EVEROLIMUS |
NOVARTIS |
Labeling |
Approval |
| 06/01/2026 |
DIAZEPAM ANDA #070311 |
SUPPL-28 |
DIAZEPAM |
HIKMA |
Manufacturing (CMC) |
Approval |
| 06/01/2026 |
SOLIRIS BLA #125166 |
SUPPL-453 |
ECULIZUMAB |
ALEXION PHARM |
|
Approval |
| 06/01/2026 |
AFINITOR DISPERZ NDA #203985 |
SUPPL-28 |
EVEROLIMUS |
NOVARTIS PHARM |
Labeling |
Approval |
| 06/01/2026 |
METHYLPREDNISOLONE ANDA #206751 |
SUPPL-10 |
METHYLPREDNISOLONE |
ZYDUS PHARMS |
Labeling |
Approval |
| 06/01/2026 |
LURASIDONE HYDROCHLORIDE ANDA #208047 |
SUPPL-3 |
LURASIDONE HYDROCHLORIDE |
DR REDDYS |
Labeling |
Approval |
| 06/01/2026 |
LURASIDONE HYDROCHLORIDE ANDA #208047 |
SUPPL-4 |
LURASIDONE HYDROCHLORIDE |
DR REDDYS |
Labeling |
Approval |
| 06/01/2026 |
OZEMPIC NDA #209637 |
SUPPL-38 |
SEMAGLUTIDE |
NOVO |
Labeling |
Approval |
| 06/01/2026 |
ERIBULIN MESYLATE ANDA #217085 |
ORIG-1 |
ERIBULIN MESYLATE |
NATCO |
|
Approval |
| 06/01/2026 |
PHYTONADIONE ANDA #217734 |
ORIG-1 |
PHYTONADIONE |
AMNEAL |
|
Approval |
| 06/01/2026 |
MYCOPHENOLATE MOFETIL ANDA #218566 |
ORIG-1 |
MYCOPHENOLATE MOFETIL |
CONCORD BIOTECH LTD |
|
Approval |
| 06/01/2026 |
FLUORESCEIN SODIUM ANDA #218651 |
ORIG-1 |
FLUORESCEIN SODIUM |
ZYDUS LIFESCIENCES |
|
Approval |
| 06/01/2026 |
CYCLOSPORINE ANDA #219288 |
ORIG-1 |
CYCLOSPORINE |
JIANGSU ANBISON |
|
Approval |
| 06/01/2026 |
PEMIGATINIB ANDA #219552 |
ORIG-1 |
PEMIGATINIB |
SANDOZ INC |
|
Tentative Approval |
| 06/01/2026 |
BELZUTIFAN ANDA #220866 |
ORIG-1 |
BELZUTIFAN |
HETERO LABS LIMITED |
|
Tentative Approval |
| 06/01/2026 |
ULTOMIRIS BLA #761108 |
SUPPL-45 |
RAVULIZUMAB-CWVZ |
ALEXION PHARM |
|
Approval |
| 06/02/2026 |
FUROSEMIDE NDA #018569 |
SUPPL-71 |
FUROSEMIDE |
EPIC PHARMA LLC |
Labeling |
Approval |
| 06/02/2026 |
LEFLUNOMIDE ANDA #077083 |
SUPPL-8 |
LEFLUNOMIDE |
BARR |
Labeling |
Approval |
| 06/02/2026 |
LEFLUNOMIDE ANDA #077083 |
SUPPL-9 |
LEFLUNOMIDE |
BARR |
Labeling |
Approval |
| 06/02/2026 |
ARSENIC TRIOXIDE ANDA #206228 |
SUPPL-13 |
ARSENIC TRIOXIDE |
ZYDUS PHARMS |
Labeling |
Approval |
| 06/02/2026 |
SAXENDA NDA #206321 |
SUPPL-24 |
LIRAGLUTIDE |
NOVO |
Labeling |
Approval |
| 06/02/2026 |
TIOCYSTIN NDA #212927 |
ORIG-1 |
TIOPRONIN |
CASPER PHARMA LLC |
Type 5 - New Formulation or New Manufacturer |
Approval |
| 06/02/2026 |
ELUXADOLINE ANDA #213511 |
ORIG-1 |
ELUXADOLINE |
AUROBINDO PHARMA |
|
Approval |
| 06/02/2026 |
OXCARBAZEPINE ANDA #215332 |
SUPPL-6 |
OXCARBAZEPINE |
AUCTA |
Labeling |
Approval |
| 06/02/2026 |
ROMIDEPSIN ANDA #219099 |
ORIG-1 |
ROMIDEPSIN |
AMNEAL |
|
Approval |
| 06/02/2026 |
RANLUSPEC BLA #761480 |
ORIG-1 |
RANIBIZUMAB-HKDZ |
LUPIN LIMITED |
|
Approval |
| 06/03/2026 |
SERTRALINE HYDROCHLORIDE ANDA #077345 |
SUPPL-14 |
SERTRALINE HYDROCHLORIDE |
HERITAGE PHARMA AVET |
Labeling |
Approval |
| 06/03/2026 |
ARGATROBAN IN DEXTROSE NDA #201743 |
SUPPL-3 |
ARGATROBAN |
SANDOZ |
Labeling |
Approval |
| 06/03/2026 |
FARXIGA NDA #202293 |
SUPPL-35 |
DAPAGLIFLOZIN |
ASTRAZENECA AB |
Labeling |
Approval |
| 06/03/2026 |
INVOKANA NDA #204042 |
SUPPL-44 |
CANAGLIFLOZIN |
JANSSEN PHARMS |
Labeling |
Approval |
| 06/03/2026 |
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE ANDA #204196 |
ORIG-1 |
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
SUN PHARM |
|
Approval |
| 06/03/2026 |
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE ANDA #208111 |
SUPPL-11 |
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE |
PADAGIS ISRAEL |
Labeling |
Approval |
| 06/03/2026 |
QTERN NDA #209091 |
SUPPL-9 |
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE |
ASTRAZENECA AB |
Labeling |
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #209633 |
ORIG-1 |
TOFACITINIB CITRATE |
BRECKENRIDGE |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #209738 |
ORIG-2 |
TOFACITINIB CITRATE |
MICRO LABS |
|
Approval |
| 06/03/2026 |
STEGLATRO NDA #209803 |
SUPPL-12 |
ERTUGLIFLOZIN |
MSD SUB MERCK |
Labeling |
Approval |
| 06/03/2026 |
STEGLUJAN NDA #209805 |
SUPPL-22 |
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE |
MSD SUB MERCK |
Labeling |
Approval |
| 06/03/2026 |
VASOPRESSIN ANDA #213988 |
SUPPL-2 |
VASOPRESSIN |
DR REDDYS |
Manufacturing (CMC) |
Approval |
| 06/03/2026 |
VASOPRESSIN ANDA #213988 |
SUPPL-3 |
VASOPRESSIN |
DR REDDYS |
Manufacturing (CMC) |
Approval |
| 06/03/2026 |
VASOPRESSIN IN DEXTROSE 5% ANDA #213988 |
SUPPL-2 |
VASOPRESSIN |
DR REDDYS |
Manufacturing (CMC) |
Approval |
| 06/03/2026 |
VASOPRESSIN IN DEXTROSE 5% ANDA #213988 |
SUPPL-3 |
VASOPRESSIN |
DR REDDYS |
Manufacturing (CMC) |
Approval |
| 06/03/2026 |
BRENZAVVY NDA #214373 |
SUPPL-2 |
BEXAGLIFLOZIN |
THERACOSBIO |
Labeling |
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #215356 |
ORIG-1 |
TOFACITINIB CITRATE |
AUROBINDO PHARMA LTD |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #217298 |
ORIG-1 |
TOFACITINIB CITRATE |
MSN |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #217299 |
ORIG-1 |
TOFACITINIB CITRATE |
MSN |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #218096 |
ORIG-1 |
TOFACITINIB CITRATE |
APOTEX |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #218407 |
ORIG-1 |
TOFACITINIB CITRATE |
SUN PHARM INDS INC |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #219395 |
ORIG-1 |
TOFACITINIB CITRATE |
SPECGX LLC |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #219530 |
ORIG-1 |
TOFACITINIB CITRATE |
MACLEODS PHARMS LTD |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #220137 |
ORIG-1 |
TOFACITINIB CITRATE |
SOMERSET THERAPS LLC |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #220458 |
ORIG-1 |
TOFACITINIB CITRATE |
APOTEX |
|
Approval |
| 06/03/2026 |
TOFACITINIB CITRATE ANDA #220458 |
ORIG-2 |
TOFACITINIB CITRATE |
APOTEX |
|
Tentative Approval |
| 06/04/2026 |
CHILDREN'S ALLEGRA ALLERGY NDA #021909 |
SUPPL-19 |
FEXOFENADINE HYDROCHLORIDE |
CHATTEM SANOFI |
Labeling |
Approval |
| 06/04/2026 |
CHILDREN'S ALLEGRA HIVES NDA #021909 |
SUPPL-19 |
FEXOFENADINE HYDROCHLORIDE |
CHATTEM SANOFI |
Labeling |
Approval |
| 06/04/2026 |
DIPYRIDAMOLE ANDA #074521 |
SUPPL-25 |
DIPYRIDAMOLE |
HIKMA |
Manufacturing (CMC) |
Approval |
| 06/04/2026 |
CANGRELOR ANDA #213703 |
ORIG-1 |
CANGRELOR |
MSN |
|
Approval |
| 06/04/2026 |
HALOPERIDOL ANDA #214470 |
ORIG-1 |
HALOPERIDOL |
ALEMBIC |
|
Approval |
| 06/04/2026 |
RAMELTEON ANDA #215243 |
SUPPL-4 |
RAMELTEON |
MICRO LABS |
Manufacturing (CMC) |
Approval |
| 06/04/2026 |
RAMELTEON ANDA #215485 |
ORIG-1 |
RAMELTEON |
HIBROW HLTHCARE |
|
Approval |
| 06/04/2026 |
DALBAVANCIN HYDROCHLORIDE ANDA #219604 |
ORIG-1 |
DALBAVANCIN HYDROCHLORIDE |
BE PHARMS |
|
Approval |
| 06/05/2026 |
LIDOCAINE HYDROCHLORIDE ANDA #040078 |
SUPPL-38 |
LIDOCAINE HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
| 06/05/2026 |
ACYCLOVIR ANDA #075211 |
SUPPL-16 |
ACYCLOVIR |
AUROBINDO PHARMA USA |
Labeling |
Approval |
| 06/05/2026 |
ACETAZOLAMIDE SODIUM ANDA #202693 |
SUPPL-12 |
ACETAZOLAMIDE SODIUM |
AVET LIFESCIENCES |
Labeling |
Approval |
| 06/05/2026 |
RABEPRAZOLE SODIUM ANDA #204237 |
SUPPL-18 |
RABEPRAZOLE SODIUM |
RUBICON RESEARCH |
Labeling |
Approval |
| 06/05/2026 |
SOTALOL HYDROCHLORIDE ANDA #207429 |
SUPPL-8 |
SOTALOL HYDROCHLORIDE |
REGCON HOLDINGS |
Labeling |
Approval |
| 06/05/2026 |
DABIGATRAN ETEXILATE MESYLATE ANDA #207961 |
SUPPL-13 |
DABIGATRAN ETEXILATE MESYLATE |
HETERO LABS LTD III |
Labeling |
Approval |
| 06/05/2026 |
ABIRATERONE ACETATE ANDA #208371 |
SUPPL-5 |
ABIRATERONE ACETATE |
RISING |
Labeling |
Approval |
| 06/05/2026 |
TOFACITINIB CITRATE ANDA #209829 |
ORIG-2 |
TOFACITINIB CITRATE |
ZYDUS PHARMS |
|
Approval |
| 06/05/2026 |
EPIDIOLEX NDA #210365 |
SUPPL-24 |
CANNABIDIOL |
JAZZ PHARMS RES |
Labeling |
Approval |
| 06/05/2026 |
EPIDIOLEX NDA #210365 |
SUPPL-29 |
CANNABIDIOL |
JAZZ PHARMS RES |
Labeling |
Approval |
| 06/05/2026 |
EPIDIOLEX NDA #210365 |
SUPPL-30 |
CANNABIDIOL |
JAZZ PHARMS RES |
Labeling |
Approval |
| 06/05/2026 |
BRIMONIDINE TARTRATE ANDA #216772 |
SUPPL-2 |
BRIMONIDINE TARTRATE |
UPSHER SMITH LABS |
Labeling |
Approval |
| 06/05/2026 |
EMGALITY BLA #761063 |
SUPPL-13 |
GALCANEZUMAB-GNLM |
ELI LILLY AND CO |
|
Approval |
| 06/05/2026 |
AJOVY BLA #761089 |
SUPPL-36 |
FREMANEZUMAB-VFRM |
TEVA PHARMS USA |
|
Approval |
| 06/05/2026 |
VYEPTI BLA #761119 |
SUPPL-15 |
EPTINEZUMAB-JJMR |
Lundbeck Seattle BioPharmaceuticals, Inc. |
|
Approval |
| 06/05/2026 |
IMULDOSA BLA #761364 |
SUPPL-5 |
USTEKINUMAB-SRLF |
ACCORD BIOPHARMA INC. |
|
Approval |
| 06/05/2026 |
HYMPAVZI BLA #761369 |
SUPPL-3 |
MARSTACIMAB-HNCQ |
PFIZER INC |
|
Approval |
| 06/06/2026 |
PROVOCHOLINE NDA #019193 |
SUPPL-32 |
METHACHOLINE CHLORIDE |
METHAPHARM |
Labeling |
Approval |
| 06/08/2026 |
ESTRADIOL ANDA #075182 |
SUPPL-30 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
Labeling |
Approval |
| 06/08/2026 |
ESTRADIOL ANDA #075182 |
SUPPL-34 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
Labeling |
Approval |
| 06/08/2026 |
ESTRADIOL ANDA #075182 |
SUPPL-38 |
ESTRADIOL |
MYLAN TECHNOLOGIES |
Labeling |
Approval |
| 06/08/2026 |
ALENDRONATE SODIUM ANDA #076584 |
SUPPL-18 |
ALENDRONATE SODIUM |
RISING |
Labeling |
Approval |
| 06/08/2026 |
RISEDRONATE SODIUM ANDA #077132 |
SUPPL-13 |
RISEDRONATE SODIUM |
TEVA PHARMS USA |
Labeling |
Approval |
| 06/08/2026 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #077446 |
SUPPL-15 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
SANDOZ |
Labeling |
Approval |
| 06/08/2026 |
RISPERIDONE ANDA #077494 |
SUPPL-27 |
RISPERIDONE |
PH HEALTH |
Labeling |
Approval |
| 06/08/2026 |
OXCARBAZEPINE ANDA #078005 |
SUPPL-12 |
OXCARBAZEPINE |
ANI PHARMS |
Labeling |
Approval |
| 06/08/2026 |
OXCARBAZEPINE ANDA #078005 |
SUPPL-15 |
OXCARBAZEPINE |
ANI PHARMS |
Labeling |
Approval |
| 06/08/2026 |
LOSARTAN POTASSIUM ANDA #078232 |
SUPPL-44 |
LOSARTAN POTASSIUM |
LUPIN LTD |
Labeling |
Approval |
| 06/08/2026 |
LOSARTAN POTASSIUM ANDA #090382 |
SUPPL-38 |
LOSARTAN POTASSIUM |
STRIDES PHARMA |
Labeling |
Approval |
| 06/08/2026 |
RISEDRONATE SODIUM ANDA #200296 |
SUPPL-8 |
RISEDRONATE SODIUM |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
| 06/08/2026 |
LEVETIRACETAM ANDA #204754 |
SUPPL-1 |
LEVETIRACETAM |
AIPING PHARM INC |
Labeling |
Approval |
| 06/08/2026 |
LEVETIRACETAM ANDA #204754 |
SUPPL-3 |
LEVETIRACETAM |
AIPING PHARM INC |
Labeling |
Approval |
| 06/08/2026 |
ATOVAQUONE ANDA #209685 |
SUPPL-10 |
ATOVAQUONE |
GLENMARK SPECLT |
Labeling |
Approval |
| 06/08/2026 |
ATOVAQUONE ANDA #210692 |
SUPPL-6 |
ATOVAQUONE |
HETERO LABS LTD III |
Labeling |
Approval |
| 06/08/2026 |
MACITENTAN ANDA #211000 |
ORIG-1 |
MACITENTAN |
AMNEAL |
|
Approval |
| 06/08/2026 |
MACITENTAN ANDA #211187 |
ORIG-1 |
MACITENTAN |
TEVA PHARMS USA INC |
|
Approval |
| 06/08/2026 |
LABETALOL HYDROCHLORIDE ANDA #212990 |
SUPPL-2 |
LABETALOL HYDROCHLORIDE |
EPIC PHARMA LLC |
Labeling |
Approval |
| 06/08/2026 |
GALLIUM GA 68 GOZETOTIDE ANDA #216410 |
ORIG-1 |
GALLIUM GA-68 GOZETOTIDE |
RADIOMEDIX |
|
Approval |
| 06/08/2026 |
SUCCINYLCHOLINE CHLORIDE ANDA #217873 |
SUPPL-3 |
SUCCINYLCHOLINE CHLORIDE |
STERISCIENCE |
Labeling |
Approval |
| 06/08/2026 |
GADOBUTROL ANDA #219146 |
ORIG-1 |
GADOBUTROL |
ZENARA |
|
Approval |
| 06/08/2026 |
OPDUALAG BLA #761234 |
SUPPL-11 |
NIVOLUMAB;RELATLIMAB-RMBW |
BRISTOL MYERS SQUIBB |
|
Approval |
| 06/09/2026 |
ZYVOX NDA #021130 |
SUPPL-50 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
| 06/09/2026 |
ZYVOX NDA #021131 |
SUPPL-48 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
| 06/09/2026 |
ZYVOX NDA #021132 |
SUPPL-50 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
| 06/09/2026 |
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER NDA #050671 |
SUPPL-43 |
VANCOMYCIN HYDROCHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-2 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-6 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-10 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-11 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-12 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
CAPECITABINE ANDA #202593 |
SUPPL-17 |
CAPECITABINE |
ACCORD HLTHCARE |
Labeling |
Approval |
| 06/09/2026 |
AZACITIDINE ANDA #204949 |
SUPPL-4 |
AZACITIDINE |
PHARMOBEDIENT |
Labeling |
Approval |
| 06/09/2026 |
AZACITIDINE ANDA #204949 |
SUPPL-6 |
AZACITIDINE |
PHARMOBEDIENT |
Labeling |
Approval |
| 06/09/2026 |
AZACITIDINE ANDA #204949 |
SUPPL-7 |
AZACITIDINE |
PHARMOBEDIENT |
Labeling |
Approval |
| 06/09/2026 |
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #206473 |
SUPPL-13 |
LINEZOLID |
HOSPIRA |
Labeling |
Approval |
| 06/09/2026 |
CEPHALEXIN ANDA #213568 |
ORIG-1 |
CEPHALEXIN |
AUROBINDO PHARMA |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #215552 |
ORIG-1 |
TOFACITINIB CITRATE |
YAOPHARMA CO LTD |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #218821 |
ORIG-1 |
TOFACITINIB CITRATE |
CONCORD BIOTECH LTD |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #218900 |
ORIG-1 |
TOFACITINIB CITRATE |
SAPTALIS PHARMS |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #219370 |
ORIG-1 |
TOFACITINIB CITRATE |
AUSON |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #219830 |
ORIG-1 |
TOFACITINIB CITRATE |
ORIENT PHARMA |
|
Approval |
| 06/09/2026 |
TOFACITINIB CITRATE ANDA #219830 |
ORIG-2 |
TOFACITINIB CITRATE |
ORIENT PHARMA |
|
Tentative Approval |
| 06/09/2026 |
EBGLYSS BLA #761306 |
SUPPL-6 |
LEBRIKIZUMAB-LBKZ |
ELI LILLY AND CO |
|
Approval |
| 06/10/2026 |
MALARONE NDA #021078 |
SUPPL-26 |
ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
GLAXOSMITHKLINE |
Labeling |
Approval |
| 06/10/2026 |
MALARONE PEDIATRIC NDA #021078 |
SUPPL-26 |
ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
GLAXOSMITHKLINE |
Labeling |
Approval |
| 06/10/2026 |
FLUORESCITE NDA #021980 |
SUPPL-12 |
FLUORESCEIN SODIUM |
ALCON LABS INC |
Labeling |
Approval |
| 06/10/2026 |
TERLIVAZ NDA #022231 |
SUPPL-4 |
TERLIPRESSIN ACETATE |
MALLINCKRODT IRELAND |
Labeling |
Approval |
| 06/10/2026 |
ARGATROBAN IN SODIUM CHLORIDE NDA #022434 |
SUPPL-14 |
ARGATROBAN |
CIPLA |
Labeling |
Approval |
| 06/10/2026 |
CLINDAMYCIN PHOSPHATE ANDA #064050 |
SUPPL-28 |
CLINDAMYCIN PHOSPHATE |
PADAGIS US |
Labeling |
Approval |
| 06/10/2026 |
VALACYCLOVIR HYDROCHLORIDE ANDA #203047 |
SUPPL-20 |
VALACYCLOVIR HYDROCHLORIDE |
HETERO LABS LTD V |
Labeling |
Approval |
| 06/10/2026 |
DORZOLAMIDE HYDROCHLORIDE ANDA #205294 |
SUPPL-8 |
DORZOLAMIDE HYDROCHLORIDE |
FDC LTD |
Labeling |
Approval |
| 06/10/2026 |
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE ANDA #207825 |
SUPPL-1 |
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE |
PHARMOBEDIENT |
Labeling |
Approval |
| 06/10/2026 |
ARGATROBAN IN SODIUM CHLORIDE NDA #209552 |
SUPPL-8 |
ARGATROBAN |
EUGIA PHARMA SPECLTS |
Labeling |
Approval |
| 06/10/2026 |
FOSAPREPITANT DIMEGLUMINE ANDA #212143 |
SUPPL-4 |
FOSAPREPITANT DIMEGLUMINE |
CHIA TAI TIANQING |
Labeling |
Approval |
| 06/10/2026 |
VORANIGO NDA #218784 |
SUPPL-4 |
VORASIDENIB |
SERVIER |
Labeling |
Approval |
| 06/10/2026 |
PROPRANOLOL HYDROCHLORIDE ANDA #219165 |
ORIG-1 |
PROPRANOLOL HYDROCHLORIDE |
PAI HOLDINGS |
|
Approval |
| 06/10/2026 |
EXDENSUR BLA #761458 |
SUPPL-2 |
DEPEMOKIMAB-ULAA |
GLAXOSMITHKLINE LLC |
|
Approval |